Bremelanotide Acetate and Tacrolimus Extended-Release Capsules
Determining the interaction of Bremelanotide Acetate and Tacrolimus Extended-Release Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: bremelanotide
Brand name: Vyleesi
Synonyms: Bremelanotide
Generic Name: tacrolimus
Brand name: Astagraf XL, Envarsus XR, Prograf, Hecoria
Synonyms: Tacrolimus (oral and injection), Tacrolimus (Systemic)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Bremelanotide Acetate-Tacrolimus Extended-Release Tablets
- Bremelanotide Acetate-Tacrolimus Granules for Suspension
- Bremelanotide Acetate-Tacrolimus Injection
- Bremelanotide Acetate-Tacrolimus Intravenous
- Bremelanotide Acetate-Tacrolimus oral and injection
- Bremelanotide Acetate-Tacrolimus Oral, Intravenous
- Tacrolimus Extended-Release Capsules-Brentuximab Intravenous
- Tacrolimus Extended-Release Capsules-Brentuximab vedotin
- Tacrolimus Extended-Release Capsules-Breo Ellipta
- Tacrolimus Extended-Release Capsules-Brethine
- Tacrolimus Extended-Release Capsules-Brethine Subcutaneous
- Tacrolimus Extended-Release Capsules-Bretylium